GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » Other Stockholders Equity

PT Indofarma Tbk (ISX:INAF) Other Stockholders Equity : Rp311,608 Mil (As of Sep. 2023)


View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk Other Stockholders Equity?

PT Indofarma Tbk's Other Stockholders Equity for the quarter that ended in Sep. 2023 was Rp311,608 Mil.

PT Indofarma Tbk's quarterly Other Stockholders Equity declined from Mar. 2023 (Rp311,608 Mil) to Jun. 2023 (Rp311,608 Mil) but then increased from Jun. 2023 (Rp311,608 Mil) to Sep. 2023 (Rp311,608 Mil).

PT Indofarma Tbk's annual Other Stockholders Equity increased from Dec. 2020 (Rp189,527 Mil) to Dec. 2021 (Rp305,082 Mil) and increased from Dec. 2021 (Rp305,082 Mil) to Dec. 2022 (Rp311,608 Mil).

PT Indofarma Tbk Other Stockholders Equity Historical Data

The historical data trend for PT Indofarma Tbk's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk Other Stockholders Equity Chart

PT Indofarma Tbk Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 192,860.47 193,186.98 189,527.01 305,081.63 311,607.93

PT Indofarma Tbk Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 305,081.63 311,607.93 311,607.93 311,607.93 311,607.93

PT Indofarma Tbk Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

PT Indofarma Tbk Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Indofarma Tbk (ISX:INAF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » Other Stockholders Equity
Comparable Companies
ISX:MERK ISX:DVLA ISX:PEHA ISX:PYFA ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085
Traded in Other Exchanges
N/A
Address
Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530
Website
http://www.indofarma.id
PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines